Image credit: Topsy.one
Maria Fernanda Guanipa on 04th Jun

Lynparza could avoid chemotherapy in breast cancer patients

Lynparza, a drug developed by AstraZeneca, can help slow down the progression of advanced breast cancer, according to a...

Read More
Daniel Contreras on 18th May

AstraZeneca’s Lynparza did not achieve ‘statistical significance’ in patients

AstraZeneca plc (NYSE: AZN) combination drug for gastric cancer did not achieve “statistical significance” in patients....

Read More